Free Trial
NASDAQ:VOR

Vor Biopharma (VOR) Stock Price, News & Analysis

Vor Biopharma logo
$31.72 -1.68 (-5.03%)
Closing price 04:00 PM Eastern
Extended Trading
$31.74 +0.02 (+0.05%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Vor Biopharma Stock (NASDAQ:VOR)

Advanced

Key Stats

Today's Range
$31.26
$33.20
50-Day Range
$27.24
$48.72
52-Week Range
$2.62
$65.80
Volume
423,069 shs
Average Volume
468,751 shs
Market Capitalization
$217.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$113.83
Consensus Rating
Hold

Company Overview

Vor Biopharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
63rd Percentile Overall Score

VOR MarketRank™: 

Vor Biopharma scored higher than 63% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Vor Biopharma has received a consensus rating of Hold. The company's average rating score is 2.36, and is based on 5 buy ratings, 5 hold ratings, and 1 sell rating.

  • Upside Potential

    Vor Biopharma has a consensus price target of $113.83, representing about 258.9% upside from its current price of $31.72.

  • Amount of Analyst Coverage

    Vor Biopharma has only been the subject of 4 research reports in the past 90 days.

  • Read more about Vor Biopharma's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Vor Biopharma is -0.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Vor Biopharma is -0.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    27.92% of the float of Vor Biopharma has been sold short.
  • Short Interest Ratio / Days to Cover

    Vor Biopharma has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vor Biopharma has recently decreased by 94.44%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Vor Biopharma does not currently pay a dividend.

  • Dividend Growth

    Vor Biopharma does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    27.92% of the float of Vor Biopharma has been sold short.
  • Short Interest Ratio / Days to Cover

    Vor Biopharma has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vor Biopharma has recently decreased by 94.44%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Vor Biopharma has a news sentiment score of 0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.37 average news sentiment score of Manufacturing companies.
  • News Coverage This Week

    MarketBeat has tracked 16 news articles for Vor Biopharma this week, compared to 3 articles on an average week.
  • Search Interest

    31 people have searched for VOR on MarketBeat in the last 30 days. This is an increase of 182% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added Vor Biopharma to their MarketBeat watchlist in the last 30 days. This is an increase of 400% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Vor Biopharma insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $17,773,312.00 in company stock.

  • Percentage Held by Insiders

    Only 0.45% of the stock of Vor Biopharma is held by insiders.

  • Percentage Held by Institutions

    97.29% of the stock of Vor Biopharma is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Vor Biopharma's insider trading history.
Receive VOR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vor Biopharma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VOR Stock News Headlines

Bitcoin grabs headlines, but smart money likes this token
Bitcoin grabs headlines, but smart money likes this token My research team has identified the token positioned at the absolute center of this incoming capital flood— a project so fundamentally essential to the crypto ecosystem that institutional investors simply cannot ignore it.tc pixel
See More Headlines

VOR Stock Analysis - Frequently Asked Questions

Vor Biopharma's stock was trading at $21.20 on January 1st, 2025. Since then, VOR shares have increased by 49.6% and is now trading at $31.72.

Vor Biopharma Inc. (NASDAQ:VOR) released its quarterly earnings data on Tuesday, August, 12th. The company reported ($43.60) EPS for the quarter, missing the consensus estimate of ($11.40) by $32.20.

Vor Biopharma shares reverse split on Thursday, September 18th 2025.The 1-20 reverse split was announced on Thursday, September 18th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 18th 2025. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Vor Biopharma (VOR) raised $150 million in an initial public offering (IPO) on Friday, February 5th 2021. The company issued 8,800,000 shares at a price of $16.00-$18.00 per share. Goldman Sachs, Evercore ISI, Barclays and Stifel served as the underwriters for the IPO.

Shares of VOR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/12/2025
Today
10/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biological Products, Except Diagnostic Substances
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VOR
Previous Symbol
NASDAQ:VOR
CIK
1817229
Web
N/A
Fax
N/A
Employees
140
Year Founded
2016

Price Target and Rating

High Price Target
$280.00
Low Price Target
$8.00
Potential Upside/Downside
+258.9%
Consensus Rating
Hold
Rating Score (0-4)
2.36
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
6,854,000
Free Float
6,823,000
Market Cap
$217.41 million
Optionable
N/A
Beta
2.07

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:VOR) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners